Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM

Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM

This study aimed to evaluate the predictive and monitoring role of somatostatin receptor (SSTR) positron emission tomography-computed tomography (PET/CT) and clinical parameters in patients with neuroendocrine liver metastases (NELM) from pancreatic neuroendocrine tumors (pNET) receiving capecitabin...

Full description

Bibliographic Details
Main Authors: Ingenerf Maria, Karim Homeira, Auernhammer Christoph, Zacherl Matthias, Wenter Vera, Winkelmann Michael, Ricke Jens, Berger Frank, Schmid-Tannwald Christine
Format: Article
Language:English
Published: Sciendo 2023-11-01
Series:Radiology and Oncology
Subjects:
prognosis
positron emission tomography–computed tomography
neuroendocrine tumors
capecitabine/temozolomide
Online Access:https://doi.org/10.2478/raon-2023-0055

Internet

https://doi.org/10.2478/raon-2023-0055

Similar Items